Nifty
:
24980.65
Sensex
:
81644.39
103.70 (0.42%)
370.64 (0.46%)
Nifty
Sensex
:
:
24980.65
81644.39
103.70 (0.42%)
370.64 (0.46%)

Suven Life Sciences Ltd.

Pharmaceuticals & Drugs - API

Rating :
60/99

BSE: 530239 | NSE: SUVEN

NSE BSE
236.60
19-Aug-2025
  • Open
  • High
  • Low
  • Previous Close
  •  231
  •  242.7
  •  227
  •  231.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  112003
  •  26395395.25
  •  299.99
  •  102.5

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,384.31
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,346.59
  • N/A
  • 29.86

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.27%
  • 2.73%
  • 23.17%
  • FII
  • DII
  • Others
  • 0.58%
  • 0.01%
  • 3.24%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -35.06
  • -13.15
  • -21.06

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 15.69
  • 5.66

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 17.38
  • 10.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.49
  • 14.59
  • 11.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -4.81
  • -14.99
  • -18.32

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
-4.82
-7.37
P/E Ratio
-49.09
-32.10
Revenue
12
7
EBITDA
-129
-166
Net Income
-105
-161
ROA
-31.2
-76.5
P/B Ratio
6.10
46.94
ROE
-32.56
-84.6
FCFF
-99
-186
FCFF Yield
-1.88
-3.52
Net Debt
-239
-60
BVPS
38.77
5.04

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
1.87
1.01
85.15%
1.47
2.39
-38.49%
1.61
2.45
-34.29%
2.57
3.06
-16.01%
Expenses
52.61
31.54
66.80%
45.29
32.67
38.63%
40.82
48.64
-16.08%
54.78
26.57
106.17%
EBITDA
-50.75
-30.54
-
-43.82
-30.29
-
-39.21
-46.19
-
-52.21
-23.51
-
EBIDTM
-2,718.16%
-3,035.69%
-2,987.12%
-1,269.94%
-2,435.22%
-1,884.66%
-2,029.07%
-768.33%
Other Income
0.60
4.01
-85.04%
1.22
4.28
-71.50%
1.63
6.07
-73.15%
4.04
5.14
-21.40%
Interest
0.00
0.02
-100.00%
0.00
0.03
-100.00%
0.01
0.03
-66.67%
0.02
0.04
-50.00%
Depreciation
1.37
1.49
-8.05%
1.35
1.51
-10.60%
1.53
1.60
-4.38%
1.46
1.73
-15.61%
PBT
-51.52
-28.04
-
-43.95
-27.54
-
-39.12
-41.77
-
-49.64
-12.68
-
Tax
0.00
0.00
0
0.00
-1.00
-
0.00
0.00
0
0.00
0.00
0
PAT
-51.52
-28.04
-
-43.95
-26.54
-
-39.12
-41.77
-
-49.64
-12.68
-
PATM
-2,759.29%
-2,787.28%
-2,995.57%
-1,112.83%
-2,429.69%
-1,704.00%
-1,929.38%
-414.38%
EPS
-2.36
-1.29
-
-2.02
-1.22
-
-1.79
-1.92
-
-2.28
-0.58
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
7.52
6.66
11.69
13.54
11.84
13.48
14.41
285.67
625.26
543.53
499.52
Net Sales Growth
-15.60%
-43.03%
-13.66%
14.36%
-12.17%
-6.45%
-94.96%
-54.31%
15.04%
8.81%
 
Cost Of Goods Sold
0.00
0.00
0.00
0.00
0.00
0.00
0.00
68.74
152.17
147.06
162.64
Gross Profit
7.52
6.66
11.69
13.54
11.84
13.48
14.41
216.93
473.09
396.47
336.88
GP Margin
99.96%
100%
100%
100%
100%
100%
100%
75.94%
75.66%
72.94%
67.44%
Total Expenditure
193.50
172.31
139.56
139.30
134.09
93.42
130.13
296.65
423.61
414.46
398.18
Power & Fuel Cost
-
0.30
0.26
0.00
0.00
0.00
1.63
19.37
33.56
31.50
29.32
% Of Sales
-
4.50%
2.22%
0%
0%
0%
11.31%
6.78%
5.37%
5.80%
5.87%
Employee Cost
-
20.82
18.99
18.62
21.02
18.53
17.41
36.49
61.27
52.17
35.64
% Of Sales
-
312.61%
162.45%
137.52%
177.53%
137.46%
120.82%
12.77%
9.80%
9.60%
7.13%
Manufacturing Exp.
-
145.00
115.15
115.72
106.53
71.16
103.25
147.09
144.07
153.86
139.49
% Of Sales
-
2177.18%
985.03%
854.65%
899.75%
527.89%
716.52%
51.49%
23.04%
28.31%
27.92%
General & Admin Exp.
-
5.96
5.09
4.63
6.09
3.31
4.96
13.48
20.66
19.45
22.48
% Of Sales
-
89.49%
43.54%
34.19%
51.44%
24.55%
34.42%
4.72%
3.30%
3.58%
4.50%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
4.89
8.57
7.46
6.73
% Of Sales
-
0%
0%
0%
0%
0%
0%
1.71%
1.37%
1.37%
1.35%
Miscellaneous Exp.
-
0.23
0.08
0.33
0.46
0.41
2.88
6.59
3.31
2.95
6.73
% Of Sales
-
3.45%
0.68%
2.44%
3.89%
3.04%
19.99%
2.31%
0.53%
0.54%
0.38%
EBITDA
-185.99
-165.65
-127.87
-125.76
-122.25
-79.94
-115.72
-10.98
201.65
129.07
101.34
EBITDA Margin
-2,473.27%
-2487.24%
-1093.84%
-928.80%
-1032.52%
-593.03%
-803.05%
-3.84%
32.25%
23.75%
20.29%
Other Income
7.49
10.90
21.13
8.45
1.60
7.75
14.04
27.25
23.27
21.09
19.62
Interest
0.03
0.17
0.30
0.41
0.67
0.94
0.55
1.91
4.63
5.68
5.88
Depreciation
5.71
5.82
6.50
6.54
4.39
4.35
4.17
14.20
24.76
21.41
17.50
PBT
-184.23
-160.75
-113.54
-124.27
-125.71
-77.47
-106.40
0.16
195.53
123.07
97.58
Tax
0.00
0.00
-1.00
0.00
0.00
-5.32
-12.18
24.06
71.84
35.88
25.74
Tax Rate
0.00%
0.00%
0.94%
0.00%
0.00%
6.87%
11.45%
15037.50%
36.74%
29.15%
26.38%
PAT
-184.23
-160.75
-105.08
-118.27
-122.00
-72.15
-94.22
-23.90
123.69
87.19
71.85
PAT before Minority Interest
-184.23
-160.75
-105.08
-118.27
-122.00
-72.15
-94.22
-23.90
123.69
87.19
71.85
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-2,449.87%
-2413.66%
-898.89%
-873.49%
-1030.41%
-535.24%
-653.85%
-8.37%
19.78%
16.04%
14.38%
PAT Growth
0.00%
-
-
-
-
-
-
-
41.86%
21.35%
 
EPS
-8.45
-7.37
-4.82
-5.42
-5.59
-3.31
-4.32
-1.10
5.67
4.00
3.29

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
109.99
270.04
375.32
96.15
108.01
143.35
239.13
767.41
667.00
595.28
Share Capital
21.81
21.81
21.81
14.54
12.73
12.73
12.73
12.73
12.73
12.73
Total Reserves
86.90
248.23
353.51
81.61
58.36
130.62
226.40
754.68
654.27
582.56
Non-Current Liabilities
1.71
1.35
2.46
3.57
4.50
12.07
24.51
30.20
28.21
40.54
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.25
22.65
37.08
Unsecured Loans
0.00
0.00
0.00
0.00
0.39
1.08
1.78
1.98
3.29
4.56
Long Term Provisions
1.71
1.35
1.88
2.00
1.73
1.72
1.49
3.69
2.84
2.39
Current Liabilities
23.49
13.52
105.03
102.21
109.81
120.03
156.97
225.83
208.05
210.62
Trade Payables
5.23
2.07
1.66
1.99
3.00
5.78
7.09
56.82
37.94
35.60
Other Current Liabilities
16.62
10.33
8.44
5.44
12.13
20.00
32.00
29.43
46.14
48.18
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
30.57
30.49
24.16
Short Term Provisions
1.64
1.12
94.92
94.78
94.68
94.25
117.88
109.01
93.49
102.68
Total Liabilities
135.19
284.91
482.81
201.93
222.32
275.45
420.61
1,023.44
903.26
846.44
Net Block
59.65
28.21
37.21
37.56
20.96
24.69
22.35
307.73
305.72
305.35
Gross Block
113.23
78.24
87.88
83.40
66.95
77.11
39.48
375.68
348.92
325.15
Accumulated Depreciation
53.58
50.03
50.67
45.83
45.99
52.42
17.13
67.95
43.19
19.80
Non Current Assets
59.71
28.23
137.32
41.44
25.74
115.95
22.37
349.61
322.10
318.79
Capital Work in Progress
0.01
0.00
0.00
3.55
4.77
0.00
0.02
24.74
9.72
7.20
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.07
0.07
0.07
Long Term Loans & Adv.
0.05
0.02
0.11
0.33
0.00
91.25
0.00
16.86
6.39
6.16
Other Non Current Assets
0.00
0.00
100.00
0.00
0.00
0.00
0.00
0.20
0.20
0.00
Current Assets
75.47
256.67
345.48
160.49
196.58
159.50
398.24
673.83
581.16
527.66
Current Investments
22.28
75.94
46.34
45.16
0.09
0.05
222.93
278.73
300.89
0.05
Inventories
0.24
0.71
0.00
0.02
0.14
0.00
0.00
139.47
92.51
83.46
Sundry Debtors
1.34
1.29
0.81
1.30
1.76
2.27
2.64
61.54
45.83
53.56
Cash & Bank
37.73
163.98
184.28
5.52
46.65
15.09
0.69
28.22
9.17
241.40
Other Current Assets
13.90
2.79
5.12
8.71
147.94
142.09
171.98
165.88
132.76
149.18
Short Term Loans & Adv.
12.82
11.97
108.93
99.78
141.25
140.72
169.20
115.53
99.87
108.96
Net Current Assets
51.99
243.16
240.46
58.28
86.77
39.48
241.27
448.00
373.11
317.04
Total Assets
135.18
284.90
482.80
201.93
222.32
275.45
420.61
1,023.44
903.26
846.45

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-154.10
-115.47
-115.98
-127.54
-96.02
-134.57
-52.61
69.94
109.17
67.50
PBT
-160.75
-106.08
-118.27
-122.00
-77.47
-106.40
0.16
195.53
123.07
97.58
Adjustment
-4.03
-22.46
-8.09
-1.09
-2.70
-8.26
-4.87
10.32
12.91
10.98
Changes in Working Capital
10.07
6.89
11.48
-3.93
-14.70
-17.13
-32.98
-92.37
7.90
-14.36
Cash after chg. in Working capital
-154.71
-121.65
-114.88
-127.02
-94.88
-131.79
-37.70
113.47
143.88
94.20
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.61
6.18
-1.10
-0.52
-1.15
-2.78
-14.92
-43.54
-34.71
-26.70
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
154.95
94.44
-247.81
-22.23
55.84
146.22
37.13
-0.61
-310.64
-38.63
Net Fixed Assets
-35.00
9.64
-0.93
-15.23
5.39
-37.61
360.92
-41.78
-26.29
-187.49
Net Investments
-60.70
-124.85
-102.35
-130.73
-53.26
117.43
21.74
-15.06
-342.87
-14.91
Others
250.65
209.65
-144.53
123.73
103.71
66.40
-345.53
56.23
58.52
163.77
Cash from Financing Activity
-0.76
-1.05
395.54
145.69
34.86
2.81
4.53
-52.07
-30.39
-68.07
Net Cash Inflow / Outflow
0.09
-22.09
31.75
-4.07
-5.33
14.45
-10.94
17.26
-231.86
-39.20
Opening Cash & Equivalents
14.93
37.02
5.27
9.35
14.68
0.23
17.89
8.69
240.55
279.75
Closing Cash & Equivalent
15.03
14.93
37.02
5.27
9.35
14.68
0.23
25.95
8.69
240.55

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
4.99
12.38
17.21
6.09
5.15
11.26
18.79
60.29
52.40
46.77
ROA
-76.53%
-27.37%
-34.54%
-57.51%
-28.99%
-27.07%
-3.31%
12.84%
9.97%
8.87%
ROE
-84.88%
-32.56%
-50.17%
-145.90%
-67.29%
-49.27%
-4.75%
17.25%
13.81%
12.50%
ROCE
-84.51%
-32.78%
-49.94%
-117.81%
-60.09%
-54.67%
0.40%
26.01%
18.19%
15.43%
Fixed Asset Turnover
0.07
0.14
0.16
0.16
0.19
0.25
1.38
1.73
1.62
1.63
Receivable days
71.91
32.67
28.38
47.15
54.60
62.22
41.00
31.34
33.32
34.19
Inventory Days
25.94
22.11
0.00
2.53
3.83
0.00
0.00
67.71
58.98
60.29
Payable days
0.00
0.00
0.00
0.00
0.00
18.53
39.04
38.79
33.17
35.72
Cash Conversion Cycle
97.84
54.79
28.38
49.67
58.43
43.70
1.96
60.26
59.13
58.77
Total Debt/Equity
0.00
0.00
0.00
0.01
0.02
0.01
0.01
0.04
0.11
0.14
Interest Cover
-964.44
-354.37
-286.20
-181.00
-81.35
-191.96
1.08
43.25
22.65
17.61

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Suven Life Sciences - Quarterly Results
    13th Aug 2025, 12:52 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.